Advisor Group Holdings, Inc. Vascular Biogenics Ltd. Transaction History

Advisor Group Holdings, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.21 - $0.32 $124 - $189	-591 Reduced 2.63%	21,900 $5,000
Q4 2022 Feb 10, 2023	SELL	$0.11 - $0.16 $132 - $192	-1,200 Reduced 5.07%	22,491 $2,000
Q3 2022 Nov 14, 2022	SELL	$0.15 - $2.1 $2,008 - $28,114	-13,388 Reduced 36.11%	23,691 $4,000
Q2 2022 Aug 10, 2022	BUY	$1.22 - $1.95 $344 - $549	282 Added 0.77%	37,079 $60,000
Q1 2022 May 04, 2022	BUY	$1.15 - $1.97 $13,952 - $23,902	12,133 Added 49.19%	36,797 $68,000
Q2 2021 Aug 02, 2021	SELL	$1.69 - $2.67 $15,510 - $24,505	-9,178 Reduced 27.12%	24,664 $58,000
Q1 2021 May 13, 2021	SELL	$1.79 - $2.91 $12,293 - $19,985	-6,868 Reduced 16.87%	33,842 $67,000
Q4 2020 Feb 10, 2021	SELL	$1.07 - $2.0 $2,443 - $4,568	-2,284 Reduced 5.31%	40,710 $77,000
Q3 2020 Nov 12, 2020	SELL	$1.11 - $1.4 $9,032 - $11,391	-8,137 Reduced 15.91%	42,994 $53,000
Q2 2020 Aug 14, 2020	SELL	$1.12 - $1.63 $142 - $207	-127 Reduced 0.25%	51,131 $65,000
Q1 2020 May 18, 2020	BUY	$0.96 - $1.57 $49,207 - $80,475	51,258 New	51,258 $69,000

416K

Ticker VBLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,348,896
Description
Vascular Biogenics Ltd., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. Its programs are based on its vascular targeting system, a gene-based technology targeting newly formed blood vessels; and monocyte targeting technology, an antib...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.